Roth MKM lowered the firm’s price target on Aspen Aerogels (ASPN) to $22 from $31 and keeps a Buy rating on the shares. The stock has moved firmly out of favor following a momentum-driven upswing, but the firm sees “favorable risk/reward”, noting that while near-term overhang remains around EV market growth trajectory, capacity expansion plans, there is clear strategic optionality and a contrarian opportunity emerging versus current sentiment, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- ASPN Upcoming Earnings Report: What to Expect?
- 3 Best Stocks to Buy Now, 1/30/2025, According to Top Analysts
- Aspen Aerogels announces agreement with AMA
- Craig-Hallum says read through from GM EV outlook not reflected in Aspen shares
- Trump Trade: President blasts EU regulators for targeting U.S. tech companies
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue